2San's new app provides vital diagnostic product insights

Healthcare apps
2San’s leap forward in self diagnostics will bring ‘Better Care, Better Life’ to all, in a new step for 2San’s post-COVID-19 healthcare technology

2San’s new app is ready to offer consumers all the healthcare data they need to know about their diagnostics products, from instructional videos to product information.


An app for better healthcare

2San is a global supplier of healthcare products and solutions, and has fast become a trusted supplier across more than 20 markets worldwide. 

The App also contains links and articles for each of the Diagnostic Products 2San offers, as well as customer support and a feedback area. Every 2San product has a QR code for customers to download the app.

"We are so excited to have launched our app to support our customers and are hugely passionate about Self Diagnostics and the positive impact this can have for our customers,” said CEO Ralph Webb. “We welcome your feedback to continually improve our customers' experience and support network. The launch of this app helps us get one step closer to achieving our goal of Better care, Better life for people around the globe.”


2San and the opportunities of healthcare technology

Valerie Palmieri, Scientific Advisor North American for 2San, recently told Healthcare Digital about post-COVID-19 healthcare technology and the roles of the three R’s in healthcare technology – Reflect, Reimagine and Reset.



“During the pandemic, we were able to give around 72.3% of the global population at least one dose of the COVID-19 vaccination - with 67% being fully vaccinated. We need to reflect on why that was possible – and how we carry that forward and continue to give more people healthcare access until everyone has it, not just in ‘first world’ countries or those that can afford it, but globally.”



“Pre-pandemic, no one could have imagined that at-home tests would become routine, or that we’d be sitting around the dinner table discussing results or medical stats as commonplace. The flip side of this, of course, is it has opened the door for healthcare to be reimagined and having the consumer understand what sensitivity and specificity is and how to select the best technology to detect disease.”



“Now, we’re at the time of reset. We’re no longer confined to all healthcare taking place in a clinical environment – but instead can make healthcare work for us, ‘where’ we are. 


“For me, working as an advisor to 2San, we are at the tipping point of a healthcare revolution where new methods and technologies will suddenly become commonplace. Creating products which expand the remit of what can be tested for by the individual means we can meet patients on their terms – adapting to when, where and how they want to be tested. This could be at home, at pharmacies or at their GP, and then they can communicate in-person, via phone, email or online. It opens a world of possibilities.” 


For more insights into Healthcare - check out the latest edition of Healthcare Digital and be sure to follow us on LinkedIn & Twitter.

Other magazines that may be of interest - Manufacturing Magazine. Check out our free upcoming virtual event, Manufacturing LIVE, 6-7th December 2023.


BizClik is a global provider of B2B digital media platforms that cover 'Executive Communities' for CEO's, CFO's, CMO's, Sustainability Leaders, Procurement & Supply Chain Leaders, Technology & AI Leaders, Cyber Leaders, FinTech & InsurTech Leaders as well as covering industries such as Manufacturing, Mining, Energy, EV, Construction, Healthcare + Food & Drink.

BizClik, based in London, Dubai & New York offers services such as Content Creation, Advertising & Sponsorship Solutions, Webinars & Events.


Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability